What the name refers to
The development name and US brand for an injectable deoxycholic acid medicine authorised for improvement of submental convexity in adults.
Evidence and regulatory context
At least one regulated medicine or indication exists for this active ingredient. Authorisation is tied to a particular formulation, manufacturer, indication and jurisdiction; it does not validate unrelated products using the same name.
Reading product records
This category is formulation- and jurisdiction-dependent. A useful record names the complete product, manufacturer, authorised distributor, batch and intended indication. An ingredient assay alone cannot establish sterility, clinical suitability or a legitimate supply chain.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.